XML 29 R5.htm IDEA: XBRL DOCUMENT v3.19.3
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
Parent
Common Stock
Capital in Excess of Par Value
Cumulative Net Income
Cumulative Distributions
Non-controlling Interests
Total
Balance at beginning of period at Dec. 31, 2017 $ 755,160,000 $ 396,000 $ 856,992,000 $ 1,100,783,000 $ (1,203,011,000) $ 3,488,000 $ 758,648,000
Balance (in shares) at Dec. 31, 2017   39,570,000          
Equity activity              
Common stock cash distributions (22,578,000)       (22,578,000)   (22,578,000)
Issuance of restricted stock (in shares)   82,000          
Stock option exercises 123,000   123,000       123,000
Stock option exercises (in shares)   5,000          
Stock-based compensation expense 1,376,000   1,376,000       1,376,000
Net income 20,359,000     20,359,000     20,359,000
Other (1,065,000)   (1,065,000)       (1,065,000)
Other (in shares)   (28,000)          
Balance at end of period at Mar. 31, 2018 753,375,000 $ 396,000 857,426,000 1,121,142,000 (1,225,589,000) 3,488,000 756,863,000
Balance (in shares) at Mar. 31, 2018   39,629,000          
Balance at beginning of period at Dec. 31, 2017 755,160,000 $ 396,000 856,992,000 1,100,783,000 (1,203,011,000) 3,488,000 $ 758,648,000
Balance (in shares) at Dec. 31, 2017   39,570,000          
Equity activity              
Stock option exercises (in shares)             5,000
Net income             $ 124,232,000
Balance at end of period at Sep. 30, 2018 815,842,000 $ 397,000 861,226,000 1,224,998,000 (1,270,779,000) 7,451,000 823,293,000
Balance (in shares) at Sep. 30, 2018   39,657,000          
Balance at beginning of period at Mar. 31, 2018 753,375,000 $ 396,000 857,426,000 1,121,142,000 (1,225,589,000) 3,488,000 756,863,000
Balance (in shares) at Mar. 31, 2018   39,629,000          
Equity activity              
Common stock cash distributions (22,590,000)       (22,590,000)   (22,590,000)
Issuance of restricted stock (8,000)   (8,000)       (8,000)
Issuance of restricted stock (in shares)   9,000          
Stock-based compensation expense 1,521,000   1,521,000       1,521,000
Net income 68,936,000     68,936,000     68,936,000
Non-controlling interests contribution           1,081,000 1,081,000
Other (107,000)   (107,000)       (107,000)
Other (in shares)   (3,000)          
Balance at end of period at Jun. 30, 2018 801,127,000 $ 396,000 858,832,000 1,190,078,000 (1,248,179,000) 4,569,000 805,696,000
Balance (in shares) at Jun. 30, 2018   39,635,000          
Equity activity              
Common stock cash distributions (22,600,000)       (22,600,000)   (22,600,000)
Proceeds from common stock issued, net of issuance costs 929,000 $ 1,000 928,000       929,000
Proceeds from common stock issued, net of issuance costs (in shares)   22,000          
Stock-based compensation expense 1,487,000   1,487,000       1,487,000
Net income 34,920,000     34,920,000   17,000 34,937,000
Non-controlling interests contribution           2,882,000 2,882,000
Non-controlling interest distributions           (17,000) (17,000)
Other (21,000)   (21,000)       (21,000)
Balance at end of period at Sep. 30, 2018 815,842,000 $ 397,000 861,226,000 1,224,998,000 (1,270,779,000) 7,451,000 823,293,000
Balance (in shares) at Sep. 30, 2018   39,657,000          
Equity activity              
Common stock cash distributions (22,604,000)       (22,604,000)   (22,604,000)
Stock-based compensation expense 1,486,000   1,486,000       1,486,000
Net income 30,766,000     30,766,000   78,000 30,844,000
Non-controlling interest distributions           (48,000) (48,000)
Balance at end of period at Dec. 31, 2018 825,490,000 $ 397,000 862,712,000 1,255,764,000 (1,293,383,000) 7,481,000 832,971,000
Balance (in shares) at Dec. 31, 2018   39,657,000          
Equity activity              
Cumulative effect of the adoption of the ASC 842 (42,808,000)     (42,808,000)     (42,808,000)
As Adjusted Balance at January 1, 2019 782,682,000 $ 397,000 862,712,000 1,212,956,000 (1,293,383,000) 7,481,000 790,163,000
Common stock cash distributions (22,931,000)       (22,931,000)   (22,931,000)
Common stock cash distributions (in shares)   48,000          
Issuance of restricted stock (1,000)   (1,000)       (1,000)
Issuance of restricted stock (in shares)   78,000          
Stock-based compensation expense 1,689,000   1,689,000       1,689,000
Net income 20,346,000     20,346,000   81,000 20,427,000
Non-controlling interests contribution           919,000 919,000
Non-controlling interest distributions           (89,000) (89,000)
Other (2,024,000)   (2,024,000)       (2,024,000)
Other (in shares)   (44,000)          
Balance at end of period at Mar. 31, 2019 779,761,000 $ 397,000 862,376,000 1,233,302,000 (1,316,314,000) 8,392,000 788,153,000
Balance (in shares) at Mar. 31, 2019   39,739,000          
Balance at beginning of period at Dec. 31, 2018 825,490,000 $ 397,000 862,712,000 1,255,764,000 (1,293,383,000) 7,481,000 $ 832,971,000
Balance (in shares) at Dec. 31, 2018   39,657,000          
Equity activity              
Stock option exercises (in shares)             5,000
Net income             $ 68,241,000
Balance at end of period at Sep. 30, 2019 785,434,000 $ 398,000 865,721,000 1,280,940,000 (1,361,625,000) 8,460,000 793,894,000
Balance (in shares) at Sep. 30, 2019   39,752,000          
Balance at beginning of period at Mar. 31, 2019 779,761,000 $ 397,000 862,376,000 1,233,302,000 (1,316,314,000) 8,392,000 788,153,000
Balance (in shares) at Mar. 31, 2019   39,739,000          
Equity activity              
Common stock cash distributions (22,653,000)       (22,653,000)   (22,653,000)
Issuance of restricted stock (6,000)   (6,000)       (6,000)
Issuance of restricted stock (in shares)   8,000          
Stock-based compensation expense 1,623,000   1,623,000       1,623,000
Net income 20,446,000     20,446,000   88,000 20,534,000
Non-controlling interests contribution           46,000 46,000
Non-controlling interest distributions           (87,000) (87,000)
Balance at end of period at Jun. 30, 2019 779,171,000 $ 397,000 863,993,000 1,253,748,000 (1,338,967,000) 8,439,000 787,610,000
Balance (in shares) at Jun. 30, 2019   39,747,000          
Equity activity              
Common stock cash distributions (22,658,000)       (22,658,000)   (22,658,000)
Stock option exercises 123,000 $ 1,000 122,000       123,000
Stock option exercises (in shares)   5,000          
Stock-based compensation expense 1,626,000   1,626,000       1,626,000
Net income 27,192,000     27,192,000   88,000 27,280,000
Non-controlling interest distributions           (67,000) (67,000)
Other (20,000)   (20,000)       (20,000)
Balance at end of period at Sep. 30, 2019 $ 785,434,000 $ 398,000 $ 865,721,000 $ 1,280,940,000 $ (1,361,625,000) $ 8,460,000 $ 793,894,000
Balance (in shares) at Sep. 30, 2019   39,752,000